Taken together, these experiments suggest that targeting FGF21 and TGFB1 may have utility for treatment of metabolic dysfunction associated with lipodystrophy and that murine housing temperature is an important variable to consider when studying therapeutic metabolic endpoints. This evidence concerns the gene FGF21 and lipodystrophy.